Overview

Diabetes Virus Detection Project, Intervention With GAD-alum

Status:
Terminated
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are to test whether GAD vaccination can stop the progression of newly diagnosed type 1 diabetes, to describe the related immunological processes (insulitis) in pancreas and small intestines evolving the mechanism of the effect of GAD vaccination and finally try to detect viruses and virus receptors directly in the insulin producing beta cells of the pancreas in patients with newly diagnosed type-1 diabetes mellitus (T1D).
Phase:
Phase 2
Details
Lead Sponsor:
Oslo University Hospital
Treatments:
Aluminum sulfate